Annual Retained Earnings:
-$340.52M+$275.19M(+44.69%)Summary
- As of today, PTGX annual retained earnings is -$340.52 million, with the most recent change of +$275.19 million (+44.69%) on December 31, 2024.
- During the last 3 years, PTGX annual retained earnings has risen by +$68.84 million (+16.82%).
- PTGX annual retained earnings is now -2611.59% below its all-time high of -$12.56 million, reached on December 31, 2014.
Performance
PTGX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$386.95M-$34.77M(-9.87%)Summary
- As of today, PTGX quarterly retained earnings is -$386.95 million, with the most recent change of -$34.77 million (-9.87%) on June 30, 2025.
- Over the past year, PTGX quarterly retained earnings has increased by +$52.04 million (+11.85%).
- PTGX quarterly retained earnings is now -1311.39% below its all-time high of -$27.42 million, reached on December 31, 2015.
Performance
PTGX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PTGX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +44.7% | +11.8% |
| 3Y3 Years | +16.8% | +17.9% |
| 5Y5 Years | -56.5% | -50.5% |
PTGX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +44.7% | -13.6% | +39.8% |
| 5Y | 5-Year | -56.5% | +44.7% | -46.1% | +39.8% |
| All-Time | All-Time | -2611.6% | +44.7% | -1311.4% | +39.8% |
PTGX Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$386.95M(-9.9%) |
| Mar 2025 | - | -$352.18M(-3.4%) |
| Dec 2024 | -$340.52M(+44.7%) | -$340.52M(+27.9%) |
| Sep 2024 | - | -$472.20M(-7.6%) |
| Jun 2024 | - | -$438.99M(-7.5%) |
| Mar 2024 | - | -$408.37M(+33.7%) |
| Dec 2023 | -$615.71M(-14.7%) | -$615.71M(+4.3%) |
| Sep 2023 | - | -$643.04M(-5.6%) |
| Jun 2023 | - | -$608.94M(-6.7%) |
| Mar 2023 | - | -$570.48M(-6.3%) |
| Dec 2022 | -$536.75M(-31.1%) | -$536.75M(-6.8%) |
| Sep 2022 | - | -$502.56M(-6.6%) |
| Jun 2022 | - | -$471.33M(-9.5%) |
| Mar 2022 | - | -$430.29M(-5.1%) |
| Dec 2021 | -$409.36M(-44.2%) | -$409.36M(-9.9%) |
| Sep 2021 | - | -$372.45M(-10.0%) |
| Jun 2021 | - | -$338.65M(-10.0%) |
| Mar 2021 | - | -$307.81M(-8.5%) |
| Dec 2020 | -$283.81M | -$283.81M(-7.1%) |
| Sep 2020 | - | -$264.93M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -$257.16M(-8.2%) |
| Mar 2020 | - | -$237.74M(-9.2%) |
| Dec 2019 | -$217.66M(-54.9%) | -$217.66M(-8.7%) |
| Sep 2019 | - | -$200.16M(-8.9%) |
| Jun 2019 | - | -$183.75M(-18.9%) |
| Mar 2019 | - | -$154.58M(-10.0%) |
| Dec 2018 | -$140.47M(-38.3%) | -$140.47M(-11.0%) |
| Sep 2018 | - | -$126.61M(-7.4%) |
| Jun 2018 | - | -$117.87M(-7.9%) |
| Mar 2018 | - | -$109.21M(-7.5%) |
| Dec 2017 | -$101.55M(-57.2%) | -$101.55M(-3.1%) |
| Sep 2017 | - | -$98.50M(-5.2%) |
| Jun 2017 | - | -$93.67M(-19.0%) |
| Mar 2017 | - | -$78.69M(-21.8%) |
| Dec 2016 | -$64.59M(-135.6%) | -$64.59M(-21.1%) |
| Sep 2016 | - | -$53.34M(-15.3%) |
| Jun 2016 | - | -$46.26M(-18.1%) |
| Mar 2016 | - | -$39.16M(-42.8%) |
| Dec 2015 | -$27.42M(-118.3%) | -$27.42M |
| Dec 2014 | -$12.56M | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual retained earnings year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly retained earnings year-on-year change?
What is Protagonist Therapeutics, Inc. annual retained earnings?
The current annual retained earnings of PTGX is -$340.52M
What is the all-time high annual retained earnings for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual retained earnings is -$12.56M
What is Protagonist Therapeutics, Inc. annual retained earnings year-on-year change?
Over the past year, PTGX annual retained earnings has changed by +$275.19M (+44.69%)
What is Protagonist Therapeutics, Inc. quarterly retained earnings?
The current quarterly retained earnings of PTGX is -$386.95M
What is the all-time high quarterly retained earnings for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly retained earnings is -$27.42M
What is Protagonist Therapeutics, Inc. quarterly retained earnings year-on-year change?
Over the past year, PTGX quarterly retained earnings has changed by +$52.04M (+11.85%)